§ Sir Michael McNair-WilsonTo ask the Secretary of State for Health (1) whether any financial assistance is to be provided to renal units to enable them to purchase stocks of erythroprotein;
(2) whether erythroprotein has passed its clinical trials; and how soon he expects it to be generally available to renal units.
§ Mr. Mellor[holding answer 12 December 1988]: Information about whether a product licence application under the Medicines Act 1968 has been made or the results of any associated trials is treated as confidential and it is not possible to say if or when this product will become generally available and on what terms.